---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-23-000045"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2023-09-11T23:59:59+00:00"
generated_at: "2026-06-10T21:39:15.816935+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Pacira board rejects Gary Pace's resignation after withhold vote; plans diverse director additions

## Summary
- At June 13 annual meeting, Dr. Gary Pace received more withhold than for votes in Class III director election.
- Pace tendered resignation per majority-vote policy; independent directors unanimously rejected it.
- Board engaged independent search firm to identify diverse candidates; expects to refresh board composition soon.
- Pace will continue as Class III director until 2026 annual meeting or until successor elected.

## SEC filing metadata
- accession: 0001396814-23-000045
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2023-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681423000045/0001396814-23-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681423000045/pcrx-20230907.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-23-000045
- JSON: https://secwatch.observer/filing/0001396814-23-000045.json
- Plain text: https://secwatch.observer/filing/0001396814-23-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.